Role of platelet-active drugs in coronary artery disease.
D001241:Aspirin / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000517:prevention & control*; D004176:Dipyridamole / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000401:mortality; D011446:Prospective Studies; D012107:Research Design; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D013997:Time Factors; D014481:United States
D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone